Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Gross Profit (2018 - 2025)

Viemed Healthcare's Gross Profit history spans 8 years, with the latest figure at $44.1 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 22.04% year-over-year to $44.1 million; the TTM value through Dec 2025 reached $155.5 million, up 16.71%, while the annual FY2025 figure was $155.5 million, 16.71% up from the prior year.
  • Gross Profit reached $44.1 million in Q4 2025 per VMD's latest filing, up from $41.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $44.1 million in Q4 2025 to a low of $17.6 million in Q2 2021.
  • Average Gross Profit over 5 years is $28.0 million, with a median of $28.0 million recorded in 2023.
  • Peak YoY movement for Gross Profit: crashed 32.02% in 2021, then soared 41.16% in 2023.
  • A 5-year view of Gross Profit shows it stood at $19.7 million in 2021, then grew by 16.45% to $22.9 million in 2022, then skyrocketed by 40.25% to $32.1 million in 2023, then grew by 12.54% to $36.1 million in 2024, then increased by 22.04% to $44.1 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Gross Profit are $44.1 million (Q4 2025), $41.3 million (Q3 2025), and $36.7 million (Q2 2025).